Found 120 with Last Name = 'rajagopalan' and Initial = 's' TargetAndrogen receptor(Homo sapiens (Human))
Novartis Institutes for BioMedical Research
Curated by ChEMBL
Novartis Institutes for BioMedical Research
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Displacement of [3H]DHT from androgen receptor in human MDA-MB-435 cells after 30 minsMore data for this Ligand-Target Pair
3D Structure (crystal)
Affinity DataIC50: 1.30nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 1.80nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 2.90nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 3.40nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 3.40nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 3.80nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 4.30nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 5.60nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 7nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 7.30nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 9.30nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 10.4nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 14.9nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 18nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 28nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 29nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 31nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 32nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 33nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 34nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 37nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 41nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 45nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 48nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 59nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 61nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 62nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
Affinity DataIC50: 62nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 63nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 65.8nMAssay Description:Compounds were screened in the TR-FRET assay with FGFR1 kinase. 5 ng of FGFR1 [Upstate, USA] kinase was used for assay. The compound was incubated wi...More data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Aurigene Discovery Technologies Ltd
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assayMore data for this Ligand-Target Pair
